Current Approach to Heart Failure (eBook)
IX, 642 Seiten
Springer International Publishing (Verlag)
978-3-319-45237-1 (ISBN)
This book is intended to be a link between guidelines and clinical practice, a complementary tool to help physicians to be well informed regarding the important field of heart failure. It will be a useful tool for professionals from all the fields of cardiology: non-invasive cardiology, interventional cardiology, electrophysiology and cardiovascular imaging.
The topic of heart failure is continuously changing, with new important information being added constantly. The pathophysiology is better understood and there is a trend for a better characterization of special groups of population, such as oncologic patients with heart failure. The new imaging techniques have become valuable tools for the diagnosis of heart failure, while pharmacological and novel cell and gene treatments have evolved enormously.
The challenge for the practitioners is making the right selection of treatment strategy that best fits a patient. This book presents detailed information on the indications, selection and mechanism of action of these treatments, whether they be mechanical circulatory devices or pharmacological treatments. The contemporary pharmacological and non-pharmacological management of heart failure has the main target of early prevention of disease progression and the avoidance of heart transplant. In the era of shortage of donors, prevention is the mainstay of the therapeutic strategy, and this is the main philosophy of our book.
Prof Maria Dorobanţu is professor of Cardiology at the University of Medicine and Pharmacy Carol Davila Bucharest, Romania, and head of the Cardiology Department of Clinical Emergency Hospital, Bucharest. She has a special interest in the assessment and treatment of acute heart failure (HF). She has been principal investigator in the the phase III RELAX-AHF and RELAX-AHF-2 trials as well as SENIORS and BEAUTIFUL trials. These trials regard the effects of the new agent serelaxin in the patients with acute HF. Between 2008 and 2014 she was member of CPC of ESC, Group of Hypertension.
Prof Marco Metra is professor of cardiology at the University of Brescia and directs the Institute of Cardiology of the University and Civil Hospital of Brescia, Italy. Prof Metra has been principal investigator and member of the Executive or Steering Committees of many trials in patients with HF. His research is focused on HF: β-blocker therapy, cardiopulmonary exercise testing and the assessment and treatment of acute HF. Prof Metra is also member of the Executive Committee or data Monitoring Committee of many major trials regarding the treatment of HF. As board member of the HF Association (HFA) of the European Society of Cardiology (ESC) from 2001 to 2008, He has been a member of the ESC's Committee for Practice Guidelines (years 2004-8), and has been co-chair of the 2008 meeting of the HFA of ESC, held in Milan in June 2008.
Prof Frank Ruschitzka is head of the HF and Transplantation Clinic at the University Hospital in Zürich, Switzerland. He specialized in internal medicine, nephrology and cardiology at the Universities of Göttingen and Zürich. In 2003, he was awarded the annual Götz-Preis of the Medical Faculty of the University of Zürich for excellence in clinical medicine and research. He is the President Elect of the HF Association of the ESC. Professor Ruschitzka's research interests focusses on delineating novel targets and therapies in coronary artery disease and HF.
Prof Maria Dorobanţu is professor of Cardiology at the University of Medicine and Pharmacy Carol Davila Bucharest, Romania, and head of the Cardiology Department of Clinical Emergency Hospital, Bucharest. She has a special interest in the assessment and treatment of acute heart failure (HF). She has been principal investigator in the the phase III RELAX-AHF and RELAX-AHF-2 trials as well as SENIORS and BEAUTIFUL trials. These trials regard the effects of the new agent serelaxin in the patients with acute HF. Between 2008 and 2014 she was member of CPC of ESC, Group of Hypertension. Prof Marco Metra is professor of cardiology at the University of Brescia and directs the Institute of Cardiology of the University and Civil Hospital of Brescia, Italy. Prof Metra has been principal investigator and member of the Executive or Steering Committees of many trials in patients with HF. His research is focused on HF: β-blocker therapy, cardiopulmonary exercise testing and the assessment and treatment of acute HF. Prof Metra is also member of the Executive Committee or data Monitoring Committee of many major trials regarding the treatment of HF. As board member of the HF Association (HFA) of the European Society of Cardiology (ESC) from 2001 to 2008, He has been a member of the ESC’s Committee for Practice Guidelines (years 2004–8), and has been co-chair of the 2008 meeting of the HFA of ESC, held in Milan in June 2008. Prof Frank Ruschitzka is head of the HF and Transplantation Clinic at the University Hospital in Zürich, Switzerland. He specialized in internal medicine, nephrology and cardiology at the Universities of Göttingen and Zürich. In 2003, he was awarded the annual Götz-Preis of the Medical Faculty of the University of Zürich for excellence in clinical medicine and research. He is the President Elect of the HF Association of the ESC. Professor Ruschitzka's research interests focusses on delineating novel targets and therapies in coronary artery disease and HF.
Evolving concepts on the basic mechanisms of heart failure.- Assessment of left ventricular systolic and diastolic dysfunction.- Right ventricular dysfunction in heart failure.- The role of atrial functional assessment in heart failure.- Assessment of secondary mitral regurgitation.- Assessment of left ventricular contractile reserve in heart failure.- Role of cardiac magnetic resonance imaging in heart failure.- The evolving role of multimodality imaging in heart failure.- Contemporary pharmacological treatment of heart failure.- Myocardial revascularization in heart failure.- Approach to arrhythmia in heart failure.- Implantable defibrillator therapy.- Cardiac resynchronization therapy.- Mechanical circulatory support.- Cell and gene therapy in heart failure.- Valvular Surgery in Heart Failure.- Percutaneous Valvular Therapies in Heart Failure.- Pretransplant evaluation.- Strategies for improving outcomes in heart transplantation.- Heart failure and hypertension.- Right heart failure.- Acute heart failure.- Heart failure in oncologic patients.- Iron Deficiency in Heart Failure.- The kidney and electrolyte imbalances in heart failure.- Prognostic factors and risk scores in heart failure.- Rehabilitation therapy in patients with heart failure.
| Erscheint lt. Verlag | 29.12.2016 |
|---|---|
| Zusatzinfo | IX, 642 p. 110 illus., 30 illus. in color. |
| Verlagsort | Cham |
| Sprache | englisch |
| Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Anästhesie |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Chirurgie | |
| Medizin / Pharmazie ► Medizinische Fachgebiete ► Urologie | |
| Schlagworte | device therapy • Heart Failure • Imaging • Mechanical Circulatory Support • medical treatment • special population • Surgical treatment |
| ISBN-10 | 3-319-45237-1 / 3319452371 |
| ISBN-13 | 978-3-319-45237-1 / 9783319452371 |
| Haben Sie eine Frage zum Produkt? |
PDF (Wasserzeichen)Größe: 22,9 MB
DRM: Digitales Wasserzeichen
Dieses eBook enthält ein digitales Wasserzeichen und ist damit für Sie personalisiert. Bei einer missbräuchlichen Weitergabe des eBooks an Dritte ist eine Rückverfolgung an die Quelle möglich.
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen dafür einen PDF-Viewer - z.B. den Adobe Reader oder Adobe Digital Editions.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen dafür einen PDF-Viewer - z.B. die kostenlose Adobe Digital Editions-App.
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich
